Literature DB >> 348473

The interaction of daunomycin with polydeoxynucleotides.

D R Phillips, A DiMarco, F Zunino.   

Abstract

The ability of daunomycin to bind to various DNA polymers has been sutided by thermal denaturation, spectrophotometric analysis and inhibition of the polymerisation reactions catalysed by Escherichia coli DNA polymerase I and rat liver DNA polymerase alpha. The quantitative binding measurements revealed that the antibiotic binds tightly to all synthetic polydeoxynucleotides studied. The results demonstrated that daunomycin can bind with equal affinity to dG . dC or dA . dT basepaired sequences. However, the number of binding sites per nucleotide for poly(dA) . poly(dT) is significantly lower than that found for poly(dA-dT) . poly(dA-dT), thus indicating an appreciable preference of the drug for the alternating copolymer. The inactivation of the template properties of the synthetic DNA polymers in the DNA polymerase system is consistent with their daunomycin binding ability. However, a lack of correlation was observed between the drug binding ability of different DNA polymers and the binding-induced stabilisation of the double helix to heat denaturation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 348473     DOI: 10.1111/j.1432-1033.1978.tb12264.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  4 in total

1.  Melting profile and temperature dependent binding constant of an anticancer drug daunomycin-DNA complex.

Authors:  Y Z Chen; E W Prohofsky
Journal:  Eur Biophys J       Date:  1996       Impact factor: 1.733

2.  In vitro transcription analysis of the role of flanking sequence on the DNA sequence specificity of adriamycin.

Authors:  H Trist; D R Phillips
Journal:  Nucleic Acids Res       Date:  1989-05-25       Impact factor: 16.971

3.  Mechanism of action of dnacin B1, a new benzoquinoid antibiotic with antitumor properties.

Authors:  S Tanida; T Hasegawa; M Yoneda
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

4.  Increased uptake of actinomycin D in Ehrlich ascites tumour cells induced by daunorubicin.

Authors:  C Lund-Andersen; T Skovsgaard; N I Nissen
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.